Literature DB >> 1459734

Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma.

R Zennadi1, L Garrigue, S Ringeard, A Ménoret, P Blanchardie, J Le Pendu.   

Abstract

We analyzed several factors which could influence the immunogenicity of colon tumor cells, using a series of clones derived from a single chemically induced rat adenocarcinoma cell line. These clones display variable tumorigenic potential in syngeneic immunocompetent animals, and it has been established that in this model the tumorigenicity of the cells depends on their ability to escape immune surveillance. The results show an absence of relationship between tumorigenicity and expression of MHC-class-I antigens, cell adhesion to rat fibroblasts or fibroblast extracellular matrix. The secretion of latent and active TGF beta I appeared to be quite variable from one clone to the other, but was unrelated to tumorigenicity. Unexpectedly, some regressive clones produced elevated levels of this cytokine, suggesting that in this model, spontaneous secretion of TGF beta I is not sufficient to impair the immune system of the host. In contrast, the more tumorigenic clones were more resistant than less tumorigenic ones to cytotoxicity mediated by NK or LAK cells. They also showed arrest of cell proliferation after reaching confluence, something not observed in the less tumorigenic clones. Finally, the strongest relationship with tumorigenicity was found for expression of blood-group carbohydrate antigens. Increased expression of blood-group-H antigen and, conversely, decreased expression of beta-galactoside precursors of this antigen correlated with increased tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459734     DOI: 10.1002/ijc.2910520618

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis.

Authors:  F Hallouin; C Goupille; M le Cabellec; J Bara; J le Pendu
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

2.  A rat experimental model for the design of vaccines against tumor associated antigens Tn and Sialyl-Tn.

Authors:  F Hallouin; C Goupille; J Rocher; J Le Pendu
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

3.  Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy.

Authors:  L M Weiskirch; Y Bar-Dagan; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.